{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 60076
    }
  },
  "results": [
    {
      "safetyreportversion": "2",
      "safetyreportid": "10003972",
      "primarysourcecountry": "UA",
      "occurcountry": "UA",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "1",
      "serious": "1",
      "seriousnessother": "1",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20140314",
      "fulfillexpeditecriteria": "1",
      "companynumb": "PHHY2014UA029972",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "NOVARTIS",
        "duplicatenumb": "PHHY2014UA029972"
      },
      "primarysource": {
        "reportercountry": "UA",
        "qualification": "5"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "46",
        "patientonsetageunit": "801",
        "patientweight": "73",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Blood glucose increased",
            "reactionoutcome": "2"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "FEMARA",
            "drugbatchnumb": "S0070",
            "drugauthorizationnumb": "020726",
            "drugstructuredosagenumb": "2.5",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "2.5 MG, QD",
            "drugadministrationroute": "048",
            "drugindication": "BREAST CANCER",
            "drugstartdateformat": "610",
            "drugstartdate": "201310",
            "drugenddateformat": "610",
            "drugenddate": "201402",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA020726"
              ],
              "brand_name": [
                "FEMARA"
              ],
              "generic_name": [
                "LETROZOLE"
              ],
              "manufacturer_name": [
                "Novartis Pharmaceuticals Corporation"
              ],
              "product_ndc": [
                "0078-0249"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "LETROZOLE"
              ],
              "rxcui": [
                "153124",
                "200064"
              ],
              "spl_id": [
                "f052c25a-d848-4b2d-8ff3-73bee0c89ad7"
              ],
              "spl_set_id": [
                "82b77d74-085f-45ac-a7dd-1f5c038bf406"
              ],
              "package_ndc": [
                "0078-0249-15"
              ],
              "nui": [
                "N0000175563",
                "N0000175080"
              ],
              "pharm_class_epc": [
                "Aromatase Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Aromatase Inhibitors [MoA]"
              ],
              "unii": [
                "7LKK855W8I"
              ]
            }
          }
        ]
      }
    }
  ]
}